- Home
- EVTC vs TVTX Comparison
EVTC vs TVTX Comparison
Compare EVTC & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTC
- TVTX
- Stock Information
- Founded
- EVTC 1988
- TVTX 2008
- Country
- EVTC United States
- TVTX United States
- Employees
- EVTC N/A
- TVTX N/A
- Industry
- EVTC EDP Services
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- EVTC Technology
- TVTX Health Care
- Exchange
- EVTC Nasdaq
- TVTX Nasdaq
- Market Cap
- EVTC 2.0B
- TVTX 1.7B
- IPO Year
- EVTC 2013
- TVTX N/A
- Fundamental
- Price
- EVTC $36.19
- TVTX $15.02
- Analyst Decision
- EVTC Buy
- TVTX Strong Buy
- Analyst Count
- EVTC 4
- TVTX 14
- Target Price
- EVTC $40.00
- TVTX $33.31
- AVG Volume (30 Days)
- EVTC 329.9K
- TVTX 1.9M
- Earning Date
- EVTC 05-07-2025
- TVTX 05-01-2025
- Dividend Yield
- EVTC 0.55%
- TVTX N/A
- EPS Growth
- EVTC 101.39
- TVTX N/A
- EPS
- EVTC 2.00
- TVTX N/A
- Revenue
- EVTC $868,960,000.00
- TVTX $273,533,000.00
- Revenue This Year
- EVTC $7.97
- TVTX $74.41
- Revenue Next Year
- EVTC $4.98
- TVTX $48.90
- P/E Ratio
- EVTC $18.16
- TVTX N/A
- Revenue Growth
- EVTC 17.39
- TVTX 75.65
- 52 Week Low
- EVTC $28.76
- TVTX $6.79
- 52 Week High
- EVTC $38.56
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- EVTC 51.37
- TVTX 35.45
- Support Level
- EVTC $36.29
- TVTX $16.37
- Resistance Level
- EVTC $36.91
- TVTX $15.48
- Average True Range (ATR)
- EVTC 0.61
- TVTX 1.00
- MACD
- EVTC -0.14
- TVTX -0.51
- Stochastic Oscillator
- EVTC 11.24
- TVTX 3.83
About EVTC Evertec Inc.
Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.